AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 103 filers reported holding AKERO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 4.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $167,337 | -92.5% | 3,584 | -93.8% | 0.00% | -100.0% |
Q1 2023 | $2,219,233 | -30.2% | 58,004 | -0.0% | 0.01% | -33.3% |
Q4 2022 | $3,179,715 | +162.8% | 58,024 | -54.7% | 0.01% | +200.0% |
Q2 2022 | $1,210,000 | +120900.0% | 128,087 | +914807.1% | 0.00% | – |
Q1 2022 | $1,000 | -99.9% | 14 | -100.0% | 0.00% | -100.0% |
Q4 2020 | $847,000 | -28.8% | 32,830 | -15.0% | 0.00% | -33.3% |
Q3 2020 | $1,189,000 | +59350.0% | 38,617 | +48782.3% | 0.00% | – |
Q2 2020 | $2,000 | – | 79 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ATP Life Science Ventures, L.P. | 5,830,203 | $169,134,000 | 18.83% |
venBio Partners LLC | 2,444,311 | $70,909,000 | 6.74% |
Versant Venture Management, LLC | 617,727 | $17,920,000 | 3.49% |
Redmile Group, LLC | 2,513,746 | $72,924,000 | 1.03% |
Boxer Capital, LLC | 831,495 | $24,122,000 | 0.82% |
Integral Health Asset Management, LLC | 85,000 | $2,466,000 | 0.70% |
Vivo Capital, LLC | 673,280 | $19,532,000 | 0.69% |
SILVERARC CAPITAL MANAGEMENT, LLC | 32,000 | $928,000 | 0.51% |
Cormorant Asset Management, LP | 742,549 | $21,541,000 | 0.48% |
HHLR ADVISORS, LTD. | 1,656,673 | $48,060,000 | 0.48% |